FAP imaging in rare cancer entities: first clinical experience in a broad spectrum of malignancies

Media type: E-Article
Title: FAP imaging in rare cancer entities : first clinical experience in a broad spectrum of malignancies
Contributor: Dendl, Katharina [Author]; Finck, Rebecca [Author]; Giesel, Frederik L. [Author]; Kratochwil, Clemens [Author]; Lindner, Thomas [Author]; Mier, Walter [Author]; Cardinale, Jens [Author]; Kesch, Claudia [Author]; Röhrich, Manuel [Author]; Rathke, Hendrik [Author]; Gampp, Heike [Author]; Ristau, Jonas [Author]; Adeberg, Sebastian [Author]; Jäger, Dirk [Author]; Debus, Jürgen [Author]; Haberkorn, Uwe [Author]; Körber, Stefan A. [Author]
Published: 2022
Published in: European journal of nuclear medicine and molecular imaging ; 49(2022), 2, Seite 721-731
Language: English
DOI: 10.1007/s00259-021-05488-9
Identifier:

Keywords: 68 Ga-FAPI ; 68 Ga-FAPI-PET/CT scan ; FAP imaging
Origination:
Footnote: Online veröffentlicht: 03. August 2021
Description: 68 Ga-FAPI (fibroblast activation protein inhibitor) is a rapidly evolving and highly promising radiotracer for PET/CT imaging, presenting excellent results in a variety of tumor entities, particularly in epithelial carcinomas. This retrospective analysis sought to evaluate the potential and impact of FAPI-PET/CT in rare cancer diseases with respect to improvement in staging and therapy, based on tracer uptake in normal organs and tumors.
Access State: Open Access

Search in field: